Beyond the Lysosome: Revolutionizing Cytoplasmic-Targeted Drug Conjugates for Manufacturing Precision Therapeutics
Time: 1:30 pm
day: Conference Day One
Details:
- Designing phospholipid drug conjugates for the purpose of cytoplasmic release to combat chemical complexities
- Moving beyond linker chemistries of cathepsin-based release profiles to leverage enzymes present only in the cytoplasm
- Varying linker chemistries to demonstrate a wide range of potent activities from the same drug payload
